Skip to main content
. 2023 Aug 3;14(8):495. doi: 10.1038/s41419-023-06027-0

Fig. 7. Schematic diagram showing the pharmacological mechanism of FDW028.

Fig. 7

FDW028, an inhibitor specifically targeted FUT8, promotes defucosylation and consequent HSC70/LAMP2A-mediated lysosomal degradation of B7-H3, and exhibits potent anti-mCRC activities.